Effects of hydroxyethyl starch-deferoxamine on arachidonic acid metabolism and small bowel wall perfusion in early sepsis

Journal of Investigative Surgery

Volumn 10, Issue 4, 1997, Pages 173-182

  Schröppel, Bernd ^a   Moch, Dieter ^a   Marzinzig, Michael ^a   Brückner, Uwe B ^a,b  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Cecal ligation puncture; Deferoxamine; Eicosanoids; Endotoxin; Energy rich phosphates; Hydroxyethyl starch; Iron chelation; Laser doppler flowmetry; Oxygen radicals; Prostacyclin; Prostaglandin f(2 ) rats; Sepsis; Thromboxane

Indexed keywords

ADENINE NUCLEOTIDE; DEFEROXAMINE; HETASTARCH; IRON CHELATE; PROSTACYCLIN; PROSTAGLANDIN; THROMBOXANE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; INTESTINE PERFUSION; INTESTINE WALL; IRON CHELATION; LASER DOPPLER FLOWMETRY; MALE; NONHUMAN; PERFUSION; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; RAT; SEPSIS; SMALL INTESTINE;

EID: 0030866683     PISSN: 08941939     EISSN: None     Source Type: Journal    
DOI: 10.3109/08941939709032154     Document Type: Article

References (40)

1. Baker CH. Vascular endothelium in sepsis and endotoxemia. J Fla Med Assoc. 1994;81:119-122.
2. 2 increase in rats with peritonitis due to cecal ligation. Circ Shock. 1985;16:297-305.
3. Oettinger W, Berger D, Beger HG. The clinical significance of prostaglandins and thromboxane as mediators of septic shock. Klin Wochenschr. 1987;65:61-68.
4. Slotman GJ, Friedman B, Brathwaite C, Mure AJ, Quinn JV, Shapiro E. Interleukin-1 mediates increased plasma levels of eicosanoids and cytokines in patients with sepsis syndrome. Shock. 1995;4:318-323.
5. Goode HF, Condey HC, Walker BE, Howdle PD, Webster NR. Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med 1995;23:646-651.
6. Moch D, Schröppel B, Schoenberg MH, Schulz HJ, Thorab FZ, Marzinzig M, Hedlund BE, Bruckner UB. Protective effects of hydroxyethyl starch deferoxamine (HES-DFO) in early sepsis. Shock. 1995;4:425-432.
7. Pons L, Droy-Lefaix MT, Braquet P, Bueno L. Role of free radicals and platelet-activating factor in the genesis of intestinal motor disturbance induced by E. coli endotoxins in rats. Gastroenterology 1991;100:946-953.
8. Fink MP, MacVittie TJ, Casey LC. Inhibition of prostaglandin synthesis restores normal hemodynamic in canine hyperdynamic sepsis. Ann Surg. 1984;200:619-626.
9. Cryer HM, Linger LS, Garrison RN, Harris PD. Prostaglandins maintain renal microvascular blood flow during hyperdynamic bacteremia. Circ Shock. 1988;26:71-88.
10. Murray MD, Brater DC. Adverse effects of nonsteroidal anti-inflammatory drugs on renal function. Ann Intern Med. 1990;112:559-560.
11. Gutteridge JMC, Richmond R, Halliwell B. Inhibition of the iron-catalyzed formation of hydroxyl radicals from superoxide and of lipid peroxidation by deferoxamine. Biochem J. 1979;184:469-472.
12. 2 formation. N Engl J Med 1988;319:689-698.
13. Sanderud J, Bjoro K, Saugstad OD. Oxygen radicals stimulate thromboxane and prostacyclin synthesis and induce vasoconstriction in pig lungs. Scand J Clin Lab Invest. 1993;53:447-455.
14. Kulmacz RJ, Lands WEM. Prostaglandin H synthase. Stoichiometry of heme cofactor. J Biol Chem. 1984;259: 6358-6363.
15. Dragsten PR, Hanson GI, Hallaway PE, Hedlund BE. First human testing of perfusol, a novel anti-oxidant compound for use in fluid resuscitation. Shock. 1995;3(Suppl 2):14. (Abst)
16. Shepherd AP, Oeberg ED. Laser-Doppler Flowmetry. Boston: Kluwer; 1990.
17. Johansson K, Ahn H, Lindhagen J, Lundgren O. Tissue penetration and measuring depth of laser Doppler flowmetry in the gastrointestinal application. Scand J Gastroenterol. 1987;22:1081-1088.
18. Berger D, Schleich S, Seidelmann M, Beger HG. Determination of an interaction between transferrin and lipopolysaccharide - An in vitro study. Eur Surg Res. 1991;23:309-316.
19. Yelich MR. Glucoregulatory, hormonal and metabolic responses to endotoxicosis or cecal ligation and puncture sepsis in the rat: A direct comparison. Circ Shock. 1990;31: 351-363.
20. 2 in septic shock: Species differences. Circ Shock. 1986;20:291-297.
21. Hyde SR, Stith RD, McCallum RE. Mortality and bacteriology of sepsis following cecal ligation and puncture in aged mice. Infect Immun. 1990;58:619-624.
22. Smith W. Prostanoid biosynthesis and mechanisms of action. Am J Physiol. 1992;263:F181-F191.
23. 2 biosynthesis in endotoxin-induced intestinal damage in the rat. Prostaglandins. 1989;38:319-333.
24. Jesmok G, Gundel R. Thromboxane-blocked swine as an experimental model of severe intravascular inflammation and septic shock. Shock. 1995;4:379-383.
25. 2 or products of activated neutrophils. Am J Med. 1991;91: 89-94.
26. 2 synthesis and lipoxygenase activity. FEBS. 1989;245:105-109.
27. Jeremy JY, Kontoghiorghes GT, Hoffbrand AV, Dandona P. The iron chelator deferoxamine and 1-alkyl-2-methyl-3-hydroxypyrid-4-ones inhibit vascular prostacyclin synthesis in vitro. Biochem J. 1988;254:239-244.
28. Iuliano L, Pedersen JZ, Pratico D, Rotilio G, Violi F. Role of hydroxyl radicals in the activation of human platelets. Eur J Biochem. 1994;221:695-704.
29. 2-like compounds are produced in vitro in humans by a non-cydooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 1990;87:9383-9387.
30. Laughton MJ, Moroney MA, Hoult JRS, Halliwell B. Effects of deferoxamine on eicosanoid production in two intact cell systems. Biochem Pharmacol. 1989;38:189-193.
31. Kreimeier U, Frey L, Denz J, Herbei T, Messmer K. Hypertonie saline dextran resuscitation during the initial phase of acute endotoxemia: Effect on regional blood flow. Crit Care Med. 1991;19:801-809.
32. Mainous MR, Ertel W, Chaudry IH, Deitch EA. The gut: A cytokine-generating organ in systemic inflammation. Shock. 1995;4:193-199.
33. Deitch EA, Bridges W, Ma L, Berg R, Specian RD, Granger DN. Hemorrhagic shock-induced bacterial translocation: the role of neutrophils and hydroxyl radicals. J Trauma. 1990;30:942-952.
34. Thomas YM, Hollander D, Freeman D, Nguyen T, Krugliak P. Oxygen free radical injury of IEC-18 small intestinal epithelial cell monolayers. Gastroenterology. 1991;100: 1533-1543.
35. Drugas GT, Paidas CN, Yahanda AM, Ferguson D, Clemens MG. Conjugated desferoxamine attenuates hepatic microvascular injury following ischemia/reperfusion. Circ Shock. 1991;34:278-283.
36. Haupt MT, Kaufman BS, Carlson RW. Fluid resuscitation in patients with increased vascular permeability. Crit Care Clin. 1992;8:341-353.
37. Sinaceur J, Ribere C, Nordmann J, Nordmann R. Deferoxamine: A scavenger of superoxide radicals? Biochem Pharmacol. 1984;33:1693-1694.
38. Maruyama M, Pieper GM, Kalyanaraman B, Hallaway PE, Hedlund BE, Gross GJ. Effects of hydroxyethyl starch conjugated deferoxamine on myocardial functional recovery following coronary occlusion and reperfusion in dogs. J Cardiovascular Pharmacol. 1991;17:166-175.
39. Davies MJ, Donkor R, Dunster CA, Gee CA, Jonas S, Willson RL. Deferoxamine (Desferal) and superoxide free radicals. Formation of an enzyme-damaging nitroxide. Biochem J. 1987;246:725-729.
40. Palmer RMJ. The discovery of nitric oxide in the vessel wall: A unifying concept in the pathogenesis of sepsis. Arch Surg. 1993;128:396-401.